Search
for
Sort by
Research 301–330 of 1000+
- Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
- Polycystic ovary syndrome
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
- COVID-19 and Sex Differences
- Adult polycystic ovary syndrome begins in childhood
- Nutritional management in women with polycystic ovary syndrome: A review study
- Polycystic Ovary Syndrome
- Control of pelage hair follicle development and cycling by complex interactions between follistatin and activin
- Alkylation of human hair keratin for tunable hydrogel erosion and drug delivery in tissue engineering applications
- Polycystic ovary syndrome and impact on health
- Fibroblast Growth Factors Stimulate Hair Growth through<i>β</i>-Catenin and Shh Expression in C57BL/6 Mice
- Anti-inflammatory, cyclooxygenase inhibitory and antioxidant activities of standardized extracts of Tridax procumbens L.
- Evidence for Masculinization of Adipokine Gene Expression in Visceral and Subcutaneous Adipose Tissue of Obese Women With Polycystic Ovary Syndrome (PCOS)
- Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata
- How to diagnose a lipodystrophy syndrome
- MicroRNA Species in Follicular Fluid Associating With Polycystic Ovary Syndrome and Related Intermediary Phenotypes
- Polycystic Ovary Syndrome: An Updated Overview Foregrounding Impacts of Ethnicities and Geographic Variations
- Emerging treatments in alopecia
- Melatonin promotes secondary hair follicle development of early postnatal cashmere goat and improves cashmere quantity and quality by enhancing antioxidant capacity and suppressing apoptosis
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Autotaxin–lysophosphatidic acid– LPA <sub>3</sub> signaling at the embryo‐epithelial boundary controls decidualization pathways
- Eupafolin nanoparticles protect HaCaT keratinocytes from particulate matter-induced inflammation and oxidative stress
- The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
- Ruxolitinib for the treatment of severe alopecia areata
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- Pre‐clinical evidences for the efficacy of tryptanthrin as a potent suppressor of skin cancer
- An Animal Model of Trichloroethylene-Induced Skin Sensitization in BALB/c Mice